Food effects on propranolol systemic and oral clearance: support for a blood flow hypothesis
- PMID: 3757404
- DOI: 10.1038/clpt.1986.198
Food effects on propranolol systemic and oral clearance: support for a blood flow hypothesis
Abstract
The influence of a high-protein meal as compared to fasting on the disposition of simultaneous intravenous and oral doses of propranolol, as well as on indocyanine green clearance, was examined in six normal subjects. The intravenous dose (0.1 mg/kg) was unlabeled propranolol and the oral dose (80 mg) was a stereospecifically deuterium-labeled pseudoracemate of propranolol. Systemic clearance of propranolol increased 38%, from 1005 +/- 57 to 1384 +/- 115 ml/min (mean +/- SE; P less than 0.05) as a result of the meal, with no change in t1/2 or apparent volume of distribution. A 12% decrease in oral clearance occurred with the meal but was not statistically significant (3717 +/- 185 ml/min, fasting; 3245 +/- 498 after meal), whereas bioavailability increased 67% (27.2% +/- 1.7% fasting; 45.5% +/- 4.3% after meal; P less than 0.01). Estimated hepatic blood flow, as measured by indocyanine green clearance, rose 34% 60 minutes after the meal (1719 +/- 155 ml/min fasting; 2304 +/- 218 ml/min after meal; P less than 0.02). A difference was observed in the oral clearance of the propranolol enantiomers in the fasting state, but this difference was unaffected by the meal. These alterations in propranolol disposition, as the result of a high-protein meal, are consistent with a transient increase in hepatic blood flow.
Similar articles
-
Effect of food on hepatic blood flow: implications in the "food effect" phenomenon.Clin Pharmacol Ther. 1983 Sep;34(3):316-23. doi: 10.1038/clpt.1983.174. Clin Pharmacol Ther. 1983. PMID: 6883907
-
Reduction of liver blood flow and propranolol metabolism by cimetidine.N Engl J Med. 1981 Mar 19;304(12):692-5. doi: 10.1056/NEJM198103193041202. N Engl J Med. 1981. PMID: 7464861
-
Influence of food on the intravenous and oral dose kinetics of propranolol in the dog.J Pharmacokinet Biopharm. 1985 Jun;13(3):229-41. doi: 10.1007/BF01065654. J Pharmacokinet Biopharm. 1985. PMID: 4087163
-
Clinical pharmacokinetics of propranolol.Clin Pharmacokinet. 1979 Mar-Apr;4(2):73-90. doi: 10.2165/00003088-197904020-00001. Clin Pharmacokinet. 1979. PMID: 378502 Review.
-
Propranolol disposition in chronic liver disease: a physiological approach.Clin Pharmacokinet. 1976;1(4):264-79. doi: 10.2165/00003088-197601040-00002. Clin Pharmacokinet. 1976. PMID: 797499 Review.
Cited by
-
Influence of diet and nutritional status on drug metabolism.Clin Pharmacokinet. 1996 Jul;31(1):47-64. doi: 10.2165/00003088-199631010-00004. Clin Pharmacokinet. 1996. PMID: 8827399 Review.
-
Clinical pharmacokinetics of buffered propranolol sublingual tablet (Promptol™)-application of a new "physiologically based" model to assess absorption and disposition.AAPS J. 2013 Jul;15(3):787-96. doi: 10.1208/s12248-013-9479-1. Epub 2013 Apr 19. AAPS J. 2013. PMID: 23605805 Free PMC article. Clinical Trial.
-
Measurement of underivatized propranolol enantiomers in serum using a cellulose-tris(3,5-dimethylphenylcarbamate) high-performance liquid chromatographic (HPLC) chiral stationary phase.Pharm Res. 1988 Mar;5(3):187-9. doi: 10.1023/a:1015921124857. Pharm Res. 1988. PMID: 3244632
-
Development and Evaluation of a Physiologically Based Pharmacokinetic Drug-Disease Model of Propranolol for Suggesting Model Informed Dosing in Liver Cirrhosis Patients.Drug Des Devel Ther. 2021 Mar 17;15:1195-1211. doi: 10.2147/DDDT.S297981. eCollection 2021. Drug Des Devel Ther. 2021. PMID: 33762817 Free PMC article.
-
Circadian changes in estimated hepatic blood flow in healthy subjects.Br J Clin Pharmacol. 1991 Nov;32(5):627-9. doi: 10.1111/j.1365-2125.1991.tb03964.x. Br J Clin Pharmacol. 1991. PMID: 1954078 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical